Home »
Nektar Therapeutics
NKTR stock today: Surges 12.1% on positive eczema trial data
Nektar Therapeutics (NASDAQ: NKTR) shares vaulted 12.1% on June 24 to close at $9.54, reversing a four-week slump of 13.2%. The surge came on heavy volume as investors cheered top-line data from the Phase IIb ... more